SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-075995
Filing Date
2024-06-28
Accepted
2024-06-28 07:30:18
Documents
22
Period of Report
2024-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418388d1_8k.htm   iXBRL 8-K 37945
2 EXHIBIT 4.1 tm2418388d1_ex4-1.htm EX-4.1 102121
3 EXHIBIT 4.2 tm2418388d1_ex4-2.htm EX-4.2 93988
4 EXHIBIT 5.1 tm2418388d1_ex5-1.htm EX-5.1 9557
5 EXHIBIT 10.1 tm2418388d1_ex10-1.htm EX-10.1 247595
6 EXHIBIT 10.2 tm2418388d1_ex10-2.htm EX-10.2 77897
7 EXHIBIT 10.3 tm2418388d1_ex10-3.htm EX-10.3 9853
8 EXHIBIT 99.1 tm2418388d1_ex99-1.htm EX-99.1 10679
12 GRAPHIC tm2418388d1_ex5-1img001.jpg GRAPHIC 36718
13 GRAPHIC tm2418388d1_ex5-1img002.jpg GRAPHIC 32840
  Complete submission text file 0001104659-24-075995.txt   1006366

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA bcli-20240627.xsd EX-101.SCH 3036
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20240627_lab.xml EX-101.LAB 34240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20240627_pre.xml EX-101.PRE 22373
25 EXTRACTED XBRL INSTANCE DOCUMENT tm2418388d1_8k_htm.xml XML 3691
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 241081369
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)